SAB Biotherapeutics, Inc. (SABS)
NASDAQ·Healthcare·Biotechnology
$3.15
+2.61%
Mkt Cap $262.04M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (8 analysts)
$11.33
Range $10.00 – $13.00
Implied Upside
+259.7%
Consensus $11.33 vs current $3.15
NASDAQ·Healthcare·Biotechnology
$3.15
+2.61%
Mkt Cap $262.04M
Buy
5
Hold
0
Sell
0
Price Target (8 analysts)
$11.33
Range $10.00 – $13.00
+259.7%
Consensus $11.33 vs current $3.15